Correlation peculiarities between morphometric and flow cytometric indexes in the rat hippocampus and somatosensory cortex afterward cerebral ischemia-reperfusion and its correction
DOI:
https://doi.org/10.63341/bmbr/4.2024.08Keywords:
mesenchymal stromal cells, cerebral ischaemia-reperfusion, morphometry, neuroapoptosis, correlation analysisAbstract
The increase in the ischaemic stroke incidence has become one of the main problems in the world due to high its disablement and mortality. The purpose of the study was to establish and analyse the correlations between the number of affected neuronal nuclei in the somatosensory cortex and hippocampus and flow cytometric indexes in rats having model cerebral ischaemia-reperfusion. The effects of mesenchymal stromal cells (acquired from human umbilical cord, rat and human adipose tissue, and rat embryonic fibroblasts and their lysate) on morphometric and flow
cytometric parameters in the hippocampus and somatosensory cortex of adult Wistar rats (at the age – 3-4 months old, with a body weight – 160-190 g, after model cerebral ischaemia-reperfusion) were explored. The neuronal nuclei total numbers per 1 mm and the ratio of the intact neuronal nuclei number to the pathologically affected neuronal nuclei number (having karyopyknosis or karyorrhexis) were counted in the somatosensory cortex and hippocampal CA1 area. Nonparametric Spearman’s correlation rank analysis was used to determine relationships between individual parameters. When using mesenchymal stromal cells having different ancestry and their lysate as therapy for ischaemiareperfusion damage to brain structures, multidirectional correlations (both direct and inverse) were found between
flow cytometry parameters and the affected neuronal nuclei number on day 7 and 14 after the ischaemia-reperfusion modelling, both in the somatosensory cortex and in the hippocampus. Thus, the results of the correlation analysis demonstrated that mesenchymal stromal cells of different ancestry have a distinct neuroprotective effect aimed at restoring neurogenesis in brain structures and suppressing the intensity of neuroapoptosis in post-perfusion injuries. The data obtained from the correlation analysis will be used to determine the most effective stem cells’ class as a neuroprotectant and further develop an injectable drug based on it for the ischaemic stroke therapy
Received: 15.08.2024 | Revised: 02.11.2024 | Accepted: 26.11.2024
References
Feigin VL, Stark BA, Johnson CO, Roth GA, Bisignano C, Abady GG, et al. Global, regional, and national burden of stroke and its risk factors, 1990-2019: A systematic analysis for the Global Burden of Disease Study 2019. Lancet Neurol. 2021;20(10):795–820. DOI: 10.1016/S1474-4422(21)00252-0
Phipps MS, Cronin CA. Management of acute ischemic stroke. BMJ. 2020;368:16983. DOI: 10.1136/bmj.l6983
Primiani CT, Vicente AC, Brannick MT, Turk AS, Mocco J, Levy EI, et al. Direct aspiration versus stent retriever thrombectomy for acute stroke: A systematic review and meta-analysis in 9127 patients. J Stroke Cerebrovasc Dis. 2019;28(5):1329–37. DOI: 10.1016/j.jstrokecerebrovasdis.2019.01.034
Li M, Tang H, Li Z, Tang W. Emerging treatment strategies for cerebral ischemia-reperfusion injury. Neuroscience. 2022;507:112–24. DOI: 10.1016/j.neuroscience.2022.10.020
Powers WJ, Rabinstein AA, Ackerson T, Adeoye OM, Bambakidis NC, Becker K, et al. Correction to: Guidelines for the early management of patients with acute ischemic stroke: 2019 update to the 2018 guidelines for the early management of acute ischemic stroke: A guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2019;50(12):440–1. DOI: 10.1161/STR.0000000000000215
Kawabori M, Shichinohe H, Kuroda S, Houkin K. Clinical trials of stem cell therapy for cerebral ischemic stroke. Int J Mol Sci. 2020;21(19):7380. DOI: 10.3390/ijms21197380
Toman NG, Grande AW, Low WC. Neural repair in stroke. Cell Transplant. 2019;28(9–10):1123–6. DOI: 10.1177/0963689719863784
Li J, Zhang Q, Wang W, Lin F, Wang S, Zhao J. Mesenchymal stem cell therapy for ischemic stroke: A look into treatment mechanism and therapeutic potential. J Neurol. 2021;268(11):4095–107. DOI: 10.1007/s00415-020-10138-5
Chung JW, Chang WH, Bang OY, Moon GJ, Kim SJ, Kim SK, et al. Efficacy and safety of intravenous mesenchymal stem cells for ischemic stroke. Neurology. 2021;96(7):1012–23. DOI: 10.1212/WNL.0000000000011440
Brooks B, Ebedes D, Usmani A, Gonzales-Portillo JV, Gonzales-Portillo D, Borlongan CV. Mesenchymal stromal cells in ischemic brain injury. Cells. 2022;11(6):1013. DOI: 10.3390/cells11061013
Li Y, Huang J, Wang J, Xia S, Ran H, Gao L, et al. Human umbilical cord-derived mesenchymal stem cell transplantation supplemented with curcumin improves the outcomes of ischemic stroke via AKT/GSK-3β/β-TrCP/Nrf2 axis. J Neuroinflammation. 2023;20(1):49. DOI: 10.1186/s12974-023-02738-5
Cao H, Cheng Y, Zhang J, Xu M, Ge L. The effect of umbilical cord mesenchymal stem cells combined with tetramethylpyrazine therapy on ischemic brain injury: A histological study. J Stroke Cerebrovasc Dis. 2020;29(12):105298. DOI: 10.1016/j.jstrokecerebrovasdis.2020.105298
Council of Europe. European Convention for the Protection of Vertebrate Animals used for Experimental and Other Scientific Purposes [Internet]. 1986 [cited 2025 Jan 10]. ETS No. 123. 1986 Mar 18. Available from: https://rm.coe.int/168007a67b
Law of Ukraine. On the Protection of Animals from Cruelty [Internet]. 2006 [cited 2025 Jan 10]. Order No. 3447-IV. 2006 Feb 21. Available from: https://zakon.rada.gov.ua/laws/show/3447-15#Text
Chen Y, Peng D, Li J, Zhang L, Chen J, Wang L, et al. A comparative study of different doses of bone marrow-derived mesenchymal stem cells improve post-stroke neurological outcomes via intravenous transplantation. Brain Res. 2023;1798:148161. DOI: 10.1016/j.brainres.2022.148161
Mehta A, Mahale R, Buddaraju K, Javali M, Acharya P, Srinivasa R. Efficacy of neuroprotective drugs in acute ischemic stroke: Is it helpful? J Neurosci Rural Pract. 2019;10(4):576–81. DOI: 10.1055/s-0039-1700790
Toyoshima A, Yasuhara T, Kameda M, Morimoto J, Takeuchi H, Wang F, et al. Intra-arterial transplantation of allogeneic mesenchymal stem cells mounts neuroprotective effects in a transient ischemic stroke model in rats: Analyses of therapeutic time window and its mechanisms. PLoS One. 2015;10(6):e0127302. DOI: 10.1371/journal.pone.0127302
Yu SP, Tung JK, Wei ZZ, Chen D, Berglund K, Zhong W, et al. Optochemogenetic stimulation of transplanted iPS-NPCs enhances neuronal repair and functional recovery after ischemic stroke. J Neurosci. 2019;39(33):6571–94. DOI: 10.1523/JNEUROSCI.2010-18.2019
Tuo QZ, Zhang ST, Lei P. Mechanisms of neuronal cell death in ischemic stroke and their therapeutic implications. Med Res Rev. 2022;42(1):259–305. DOI: 10.1002/med.21817
Taei AA, Dargahi L, Khodabakhsh P, Kadivar M, Farahmandfar M. Hippocampal neuroprotection mediated by secretome of human mesenchymal stem cells against experimental stroke. CNS Neurosci Ther. 2022;28(9):1425–38. DOI: 10.1111/cns.13886
Yatsenko K, Lushnikova I, Ustymenko A, Patseva M, Govbakh I, Kyryk V, et al. Adipose–derived stem cells reduce lipopolysaccharide-induced myelin degradation and neuroinflammatory responses of glial cells in mice. J Pers Med. 2020;10(3):66. DOI: 10.3390/jpm10030066
Van Velthoven CT, Dzietko M, Wendland MF, Derugin N, Faustino J, Heijnen CJ, et al. Mesenchymal stem cells attenuate MRI-identifiable injury, protect white matter, and improve long-term functional outcomes after neonatal focal stroke in rats. J Neurosci Res. 2017;95(5):1225–36. DOI: 10.1002/jnr.23954
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 Bulletin of Medical and Biological Research
This work is licensed under a Creative Commons Attribution 4.0 International License.
